FindTrial
Sign In

Predictive value of revised Rockall rebleeding and death risk score for rebleeding after endoscopic treatment of AUGIB

Construction of doctor-nurse integrated enhanced recovery system after surgery for the endoscopic treatment of upper gastrointestinal bleeding

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100051978
Enrollment
Unknown
Registered
2021-10-11
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute non-variceal upper gastrointestinal bleeding

Interventions

death&#32
risk&#32
score.
Gold Standard:Patients with rebleeding, endoscopic lesions of Forrest class IIb or higher, and death were defined as the high-risk group and otherwise as the low-risk group, and this was used as the "
Index test:Revised-Rockall&#32
rebleeding&#32
and&#32

Sponsors

The First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Endoscopic treatment during hospitalization; 2.Conform to the diagnostic criteria of ANVUGIB in the Guidelines for the Diagnosis and Treatment of Acute Nonvariceal Upper Gastrointestinal Bleeding (2018, Hangzhou); 3.Endoscopic confirmation of the bleeding lesion.

Exclusion criteria

Exclusion criteria: 1.ANUGIB accompanied by variceal bleeding; 2.ANUGIB occurred during hospitalization due to non-digestive tract disease admission; 3.Treat patients who are transferred or discharged on their own.

Design outcomes

Primary

MeasureTime frame
rebleeding;death;therapeutic measures;—

Countries

China

Contacts

Public ContactZhang Qiaoxian

The First Affiliated Hospital of Fujian Medical University

qiaoxianzhang@163.com+86 13860624411

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026